Repaglinide and Abdominal pain upper - a phase IV clinical study of FDA data

Summary:

Abdominal pain upper is reported as a side effect among people who take Repaglinide (repaglinide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Metformin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Abdominal pain upper when taking Repaglinide. It is created by eHealthMe based on reports of 8,187 people who have side effects when taking Repaglinide from the FDA, and is updated regularly.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

What is Abdominal pain upper?

Abdominal pain upper is found to be associated with 2,958 drugs and 4,497 conditions by eHealthMe. Check the latest studies of Abdominal pain upper.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

8,187 people reported to have side effects when taking Repaglinide.
Among them, 80 people (0.98%) have Abdominal pain upper.

Could Repaglinide cause Abdominal pain upper?

Among these 80 people:

How long have people been on Repaglinide when they have Abdominal pain upper? *

What is the gender of people who have Abdominal pain upper when taking Repaglinide? *

female: 51.9 %
male: 48.1 %

What is the age of people who have Abdominal pain upper when taking Repaglinide? *

What are other drugs people take besides Repaglinide? *

Metformin: 26 people, 32.50%
Lantus: 13 people, 16.25%
Lyrica: 11 people, 13.75%
Pantoprazole: 11 people, 13.75%
Omeprazole: 8 people, 10.00%
Trulicity: 8 people, 10.00%
Paracetamol: 7 people, 8.75%
Advair Hfa: 6 people, 7.50%
Levothyroxine Sodium: 6 people, 7.50%
Diltiazem Hydrochloride: 6 people, 7.50%

What are other side effects people have besides Abdominal pain upper? *

Nausea (feeling of having an urge to vomit): 26 people, 32.50%
Weakness: 22 people, 27.50%
Diarrhea: 21 people, 26.25%
Nausea And Vomiting: 18 people, 22.50%
Dizziness: 14 people, 17.50%
Constipation: 13 people, 16.25%
General Physical Health Deterioration (weak health status): 11 people, 13.75%
Lung Disorder (lung disease): 11 people, 13.75%
Malaise (a feeling of general discomfort or uneasiness): 11 people, 13.75%
Abdominal Pain: 11 people, 13.75%

What are the existing conditions these people have? *

Type 2 Diabetes: 23 people, 28.75%
High Blood Pressure: 11 people, 13.75%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 11.25%
Pain: 6 people, 7.50%
Neck Pain: 6 people, 7.50%
Lung Neoplasm Malignant (cancer tumour of lung): 6 people, 7.50%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 6 people, 7.50%
Renal Cell Carcinoma (a kidney cancer): 4 people, 5.00%
Multiple Myeloma (cancer of the plasma cells): 4 people, 5.00%
High Blood Cholesterol: 4 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Repaglinide and have Abdominal pain upper?

- Check whether Abdominal pain upper is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Repaglinide:

Repaglinide (8,226 reports)

Browse all side effects of Repaglinide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal pain upper:

Abdominal pain upper (2,958 drugs)

Browse all the conditions that are associated with Abdominal pain upper:

Abdominal pain upper (4,497 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on repaglinide (the active ingredients of Repaglinide) and Repaglinide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.